Zoetis Inc. (ZTS) Presents at BofA Securities Animal Health Summit Transcript
Alliance Wealth Advisors LLC UT trimmed its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 21.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,188 shares of the company's stock after selling 4,430 shares during the
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
| Specialty Retail Industry | Consumer Discretionary Sector | Kristin C. Peck CEO | XMIL Exchange | US98978V1035 ISIN |
| US Country | 13,800 Employees | 20 Apr 2026 Last Dividend | - Last Split | 1 Feb 2013 IPO Date |
Zoetis Inc. is a global leader in the discovery, development, manufacture, and commercialization of a wide range of animal health medicines, vaccines, and diagnostic products. Founded in 1952 and based in Parsippany, New Jersey, the company addresses the health needs of both livestock—including cattle, swine, poultry, fish, and sheep—and companion animals, such as dogs, cats, and horses. With a presence in both the United States and international markets, Zoetis delivers products and services designed to meet the complex challenges of animal health, ensuring the well-being of animals across the globe. The company's extensive product line-up, alongside innovative diagnostic solutions, makes it a vital player in promoting animal health and supporting the veterinarians, livestock producers, and pet owners who care for them.
Zoetis Inc. offers an expansive portfolio of products and services designed to enhance animal health and support the professionals who work with animals. These include: